icon-folder.gif   Conference Reports for NATAP  
 
  IDSA/IDWeek
2015, October 7-11
San Diego
Back grey_arrow_rt.gif
 
 
 
HCV Cascade/Barriers in Philadelphia - "Meet the Professor:
Overcoming barriers to HCV care"

 
 
  Reported by Jules Levin
IDSA 2015 Oct 7-11 2015 San Diego, CA
 
Stacey B. Trooskin MD PhD
Drexel University College of Medicine
Philadelphia, PA
 
"The prevalence of HCV is high in our urban primary care practices....6029 patients tested, anti-HCV seroprevalence 8.23%.....integrating HCV testing into existing HIV & STI testing programs has advantages, 1183 tested, anti-HCV seroprevalence 11.5%...."Do One Thing" street outreach/testing, 1301 tested.....anti-HCV seroprevalence 3.9%/2.8% chronically infected: 58% were aware of infection but not engaged in care; 36% uninsured; 2 were insured but lacked PCP; 58% had an AUDIT-C score commensurate with an alcoholic use disorder; 80% had serious comorbidities such as mental illness & addiction"
 
New Philadelphia Study Highlights Need for HCV Community-Based Screening ($200 million needed)......http://www.natap.org/2014/HCV/021815_01.htm
 
Philadelphia/Impact of Integrating EMR HCV Testing Prompts in a Difficult to Navigate EMR System......http://www.natap.org/2015/CROI/croi_165.htm
 
Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program.....JGIM/July 2015
......http://www.natap.org/2014/HCV/021715_03.htm.......community-based HIV and HCV screening and linkage-to-care program in a medically underserved Philadelphia neighborhood with high rates of HIV and HCV infection

IDSA1.gif

IDSA2.gif

IDSA3.gif

IDSA4.gif

IDSA5.gif

IDSA6.gif

IDSA7.gif

IDSA8.gif

IDSA9.gif

IDSA10.gif

IDSA11.gif

IDSA12.gif